BHB
TEVA icon

Bank Hapoalim BM’s Teva Pharmaceuticals TEVA Stock Holding History

Bank Hapoalim BM’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,438
Closed -$84K – 242
2021
Q4 		$84K Sell
10,438
-49,600
-83% -$448K 0.01% 242
2021
Q3 		$585K Sell
60,038
-9,000
-13% -$84.3K 0.06% 154
2021
Q2 		$683K Sell
69,038
-12,011
-15% -$127K 0.08% 151
2021
Q1 		$935K Buy
+81,049
New +$929K 0.12% 123
2020
Q3 		– Sell
-84,748
Closed -$1.04M – 195
2020
Q2 		$1.04M Buy
+84,748
New +$958K 0.24% 76
2018
Q4 		– Sell
-15,515
Closed -$334K – 191
2018
Q3 		$334K Buy
15,515
+5,960
+62% +$138K 0.08% 149
2018
Q2 		$232K Buy
+9,555
New +$195K 0.06% 169
2018
Q1 		– Sell
-49,232
Closed -$933 – 206
2017
Q4 		$933 Buy
49,232
+21,279
+76% +$320K 0.2% 84
2017
Q3 		$492K Buy
27,953
+14,055
+101% +$316K 0.11% 140
2017
Q2 		$462K Buy
13,898
+2,225
+19% +$68.9K 0.11% 131
2017
Q1 		$375K Buy
11,673
+980
+9% +$33.4K 0.09% 141
2016
Q4 		$388K Sell
10,693
-34,855
-77% -$1.39M 0.1% 132
2016
Q3 		$2.1M Sell
45,548
-12,680
-22% -$662K 0.49% 45
2016
Q2 		$2.92M Buy
58,228
+6,080
+12% +$324K 0.68% 39
2016
Q1 		$2.79M Buy
52,148
+5,292
+11% +$311K 0.66% 38
2015
Q4 		$3.08M Sell
46,856
-2,869
-6% -$177K 0.7% 36
2015
Q3 		$2.81M Sell
49,725
-1,875
-4% -$122K 0.65% 37
2015
Q2 		$3.05M Sell
51,600
-3,223
-6% -$199K 0.6% 38
2015
Q1 		$3.42M Sell
54,823
-4,585
-8% -$267K 0.63% 39
2014
Q4 		$3.42M Sell
59,408
-2,025
-3% -$113K 0.73% 27
2014
Q3 		$3.3M Sell
61,433
-3,900
-6% -$207K 0.77% 27
2014
Q2 		$3.42M Sell
65,333
-4,452
-6% -$228K 0.84% 26
2014
Q1 		$3.69M Buy
69,785
+5,330
+8% +$246K 1.01% 21
2013
Q4 		$2.58M Buy
+64,455
New +$2.54M 0.79% 27

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Bank Hapoalim BM's TEVA Position: Q1 2022 in Review

Bank Hapoalim BM sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 10,438 shares — an estimated $84K sold.

Bank Hapoalim BM first reported a position in TEVA in Q4 2013 and held it in 24 quarters. The position peaked at $3.69M in Q1 2014. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • Bank Hapoalim BM reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Bank Hapoalim BM sold 10,438 Teva Pharmaceuticals shares in Q1 2022, an estimated $84K.
  • Bank Hapoalim BM first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 24 quarters.
  • Bank Hapoalim BM's Teva Pharmaceuticals position peaked at $3.69M in Q1 2014.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.

Based on Bank Hapoalim BM's 13F filing for Q1 2022, filed 28 Apr 2022.